| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.15M | - | |
| Dir | 4.52M | $14.38M | - | |
| CEO | 2.26M | $7.19M | - | |
| Dir | 1.24M | $3.95M | - | |
| Other | 1.11M | $3.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $7.18 | $287,200.00 | -2.6% | -34.4% | -32.3% | |
| Dec 5, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $7.14 | $285,600.00 | -2.6% | -0.2% | -28.5% | |
| Nov 14, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $7.55 | $301,800.00 | -2.6% | +20.7% | -40.1% | |
| Nov 13, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 30,000 | $7.65 | $229,504.50 | -1.0% | +4.6% | -40.8% | |
| Nov 12, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $7.64 | $87,457.37 | -0.2% | +0.9% | -38.7% | |
| Oct 29, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $6.72 | $76,926.13 | -0.2% | +4.3% | -12.9% | |
| Oct 24, 2024 | Marriott Tina73 | President And COO | Sale+OE | 6,000 | $6.31 | $37,854.60 | -1.1% | +17.8% | -5.0% | |
| Oct 15, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $6.67 | $76,326.31 | -0.2% | +1.0% | +1.8% | |
| Oct 9, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 30,000 | $6.34 | $190,131.00 | -1.0% | +21.8% | -3.9% | |
| Oct 3, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $6.12 | $244,800.00 | -2.6% | +19.0% | -9.4% |